Cosmetics Regulation: Fda Compliance, Labeling, and Market Entry

The FD&C Act defines a cosmetic by its intended use. Products that serve both cosmetic and drug purposes, called cosmeceuticals, must comply with both cosmetic and drug regulatory frameworks. A company that makes structure or function claims about how its product affects the body risks reclassifying its cosmetic as a drug requiring pre-market approval. A moisturizer intended solely to hydrate skin is a cosmetic. The same product marketed to treat or prevent a skin condition crosses into drug territory.

FDA regulatory counsel evaluates the intended use claims for each product, identifies any language that could trigger drug classification, and advises on the marketing and labeling modifications required to maintain cosmetic regulatory status.

MoCRA created the most significant changes to cosmetic safety regulation since the FD&C Act was enacted. FDA facility registration is now mandatory for all facilities that manufacture or process cosmetics. All cosmetic products must be listed with the FDA, including the product's cosmetic function and the manufacturing facility. The responsible person, whose name appears on the label, bears primary legal responsibility for safety and compliance. Registration must be renewed biennially. Failure to register, list, or maintain required records is a prohibited act under the FD&C Act.

Consumer protection law counsel advises responsible persons on their MoCRA registration and listing obligations, evaluates the adequacy of existing safety records against the MoCRA substantiation standard, and advises on the compliance calendar for mandatory FDA submissions.

Cosmetics with a prohibited ingredient or violating Good Manufacturing Practice (GMP) standards are adulterated under the FD&C Act. GMP requirements govern facility conditions, equipment, personnel, and quality control procedures. Prohibited ingredients include bithionol, hexachlorophene, and methylene chloride. Color additives must be specifically approved by FDA before use. An unapproved color additive renders the product adulterated per se.

Advertising and marketing law counsel evaluates the ingredient composition of each product against the FDA prohibited and restricted ingredients list, identifies color additive compliance issues, and advises on the GMP documentation required to support regulatory inspections.

Cosmetic labeling requirements are governed by the FD&C Act and the Fair Packaging and Labeling Act (FPLA). The ingredient declaration must list all ingredients in descending order of predominance using INCI names. Every cosmetic must bear the name and address of the responsible person, the net quantity of contents, and directions for safe use when necessary. MoCRA now requires disclosure of fragrance allergens above a defined concentration threshold. A cosmetic that lacks required labeling elements is misbranded and may be seized or refused at import.

Consumer class actions counsel evaluates the adequacy of existing product labels against all applicable FDA and FTC labeling requirements, identifies disclosure deficiencies that create class action exposure, and advises on label revision strategies that minimize both regulatory and litigation risk.

Before marketing a cosmetic, a company must confirm its classification as a cosmetic rather than a drug. It must ensure that all ingredients are permitted and that color additives are approved. MoCRA requires that safety be supported by adequate substantiation before the product reaches consumers. The responsible person must register the manufacturing facility and list the product with FDA. Imported cosmetics must comply with all FDA requirements for domestic cosmetics and are subject to examination and detention at the border.

Import and trade compliance counsel advises importers and foreign manufacturers on FDA import requirements for cosmetics, manages FDA entry documentation for imported cosmetics, and develops strategies for addressing import detentions and refusals.

The FTC regulates advertising claims under Section 5 of the FTC Act. Structure-function claims that imply the product affects the body's structure or function risk reclassifying the cosmetic as a drug subject to FDA pre-market approval. Skin firming, anti-aging, and collagen-boosting claims are high-risk categories. Organic and natural claims require factual support. The FTC expects advertising claims to be truthful, non-deceptive, and backed by reliable scientific evidence.

Brand trademark registration counsel evaluates each advertising claim for FTC compliance, identifies structure-function claims that risk FDA drug classification, and advises on the substantiation requirements applicable to each claim category.

FDA's enforcement tools include warning letters, import alerts, seizure, injunctions, and mandatory recall authority under MoCRA. A warning letter is FDA's first formal enforcement action. Ignoring one accelerates the risk of seizure or injunction. Mandatory recall authority allows FDA to require a recall of a cosmetic that presents a reasonable probability of serious adverse health consequences. Adverse event reporting is mandatory under MoCRA. Responsible persons must submit reports of serious adverse events to FDA within 15 days. Failure to report is itself a prohibited act.

Product liability and mass torts counsel evaluates the company's exposure to FDA enforcement and product liability claims arising from formulation, labeling, or manufacturing deficiencies, and develops the litigation defense strategy for cosmetic injury claims.

An effective cosmetics compliance program begins with a complete product inventory and regulatory classification review. Each product must be evaluated for ingredient compliance, color additive approval, safety substantiation, and labeling. Facility registration and product listing must be current and accurate under MoCRA. Adverse event monitoring and reporting procedures must be in place before any product reaches consumers. Employee training on GMP requirements must be documented. Internal audits of formulation, labeling, and advertising claims should occur at least annually.

Compliance program design counsel designs the cosmetics compliance program, implements the adverse event monitoring and MoCRA reporting calendar, and advises on the internal audit structure required to maintain continuous compliance with FDA and FTC requirements.